Page last updated: 2024-08-02 22:03:29
carbon-11 methionine
Description
carbon-11 methionine: RN refers to L-methionine labeled with carbon-11 [MeSH]
Cross-References
Synonyms (6)
| Synonym |
|---|
| carbon-11 methionine |
| methionine c 11 |
| 58576-49-1 |
| D04984 |
| CHEMBL2106977 |
| methionine-c11 |
Research
Studies (157)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 28 (17.83) | 18.2507 |
| 2000's | 38 (24.20) | 29.6817 |
| 2010's | 69 (43.95) | 24.3611 |
| 2020's | 22 (14.01) | 2.80 |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 19 (11.73%) | 5.53% |
| Reviews | 10 (6.17%) | 6.00% |
| Case Studies | 35 (21.60%) | 4.05% |
| Observational | 1 (0.62%) | 0.25% |
| Other | 97 (59.88%) | 84.16% |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|
| Aberrant Tissue | 0 | | 1996 | 2015 | 18.5 | low | 0 | 0 | 1 | 0 | 1 | 0 |
| Absence Seizure | 0 | | 1998 | 2022 | 14.0 | low | 0 | 0 | 1 | 0 | 0 | 1 |
| Acquired Language Disorders | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Adenocarcinoma | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Adenocarcinoma, Basal Cell | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Adenoma | 0 | | 1996 | 2023 | 13.4 | low | 0 | 0 | 1 | 4 | 6 | 1 |
| Adenoma, Basal Cell | 0 | | 1996 | 2023 | 13.4 | low | 0 | 0 | 1 | 4 | 6 | 1 |
| Adenomatosis, Familial Endocrine | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Adrenocorticotropic Hormone, Inappropriate Secretion | 0 | | 2023 | 2023 | 1.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| Age-Related Memory Disorders | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Aging | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| AIDS-Associated Lymphoma | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| AIDS-Related Opportunistic Infections | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Anaplastic Astrocytoma | 0 | | 1995 | 2021 | 19.4 | low | 0 | 0 | 5 | 1 | 2 | 1 |
| Anaplastic Ependymoma | 0 | | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Anaplastic Oligodendroglioma | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| Angioblastic Meningioma | 0 | | 1996 | 2013 | 19.5 | low | 0 | 0 | 1 | 0 | 1 | 0 |
| Anterior Cerebral Circulation Infarction | 0 | | 2012 | 2020 | 8.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| Anterior Choroidal Artery Infarction | 0 | | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Argentaffinoma | 0 | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Astroblastoma | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Astrocytoma | 0 | | 1995 | 2021 | 19.4 | low | 0 | 0 | 5 | 1 | 2 | 1 |
| Astrocytoma, Grade IV | 0 | | 1996 | 2023 | 11.9 | low | 3 | 0 | 2 | 1 | 6 | 3 |
| Atrophy | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Aura | 0 | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Auricular Cancer | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Benign Frontal Childhood Epilepsy | 0 | | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Benign Meningeal Neoplasms | 0 | | 1996 | 2013 | 17.0 | low | 0 | 0 | 1 | 0 | 2 | 0 |
| Benign Neoplasms | 0 | | 2001 | 2023 | 12.0 | low | 0 | 0 | 0 | 1 | 2 | 1 |
| Benign Neoplasms, Brain | 0 | | 1994 | 2023 | 14.4 | medium | 10 | 0 | 13 | 19 | 28 | 8 |
| Benign Supratentorial Neoplasms | 0 | | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Besnier-Boeck Disease | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Bilateral Headache | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Bone Cancer | 0 | | 1996 | 2009 | 21.5 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| Bone Neoplasms | 0 | | 1996 | 2009 | 21.5 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| Brachial Paresis | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Brain Abscess | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Brain Diseases | 0 | | 1998 | 2012 | 19.0 | low | 0 | 0 | 1 | 0 | 1 | 0 |
| Brain Disorders | 0 | | 1998 | 2012 | 19.0 | low | 0 | 0 | 1 | 0 | 1 | 0 |
| Brain Hemorrhage, Cerebral | 0 | | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Brain Infarction | 0 | | 2012 | 2020 | 8.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| Brain Inflammation | 0 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| Brain Neoplasms | 0 | | 1994 | 2023 | 14.4 | medium | 10 | 0 | 13 | 19 | 28 | 8 |
| Brain Stem Neoplasms | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Brain Stem Neoplasms, Primary | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Breast Cancer | 0 | | 1996 | 2009 | 19.3 | low | 0 | 0 | 1 | 2 | 0 | 0 |
| Breast Neoplasms | 0 | | 1996 | 2009 | 19.3 | low | 0 | 0 | 1 | 2 | 0 | 0 |
| Cancer of Cervix | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Cancer of Endometrium | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Cancer of Head | 0 | | 1998 | 2006 | 23.0 | low | 1 | 0 | 2 | 1 | 0 | 0 |
| Cancer of Larynx | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Cancer of Lung | 0 | | 1995 | 2009 | 22.8 | low | 1 | 0 | 5 | 3 | 0 | 0 |
| Cancer of Mediastinum | 0 | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Cancer of Nose | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Cancer of Ovary | 0 | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Cancer of Parathyroid | 0 | | 1996 | 2023 | 13.2 | low | 0 | 0 | 1 | 4 | 7 | 1 |
| Cancer of Pituitary | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Cancer of Rectum | 0 | | 2002 | 2002 | 22.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| Cancer of Skin | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Cancer, Embryonal | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Cancer, Radiation-Induced | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Carcinoid Tumor | 0 | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Carcinoma | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Carcinoma, Adenosquamous | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Carcinoma, Anaplastic | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Carcinoma, Epidermoid | 0 | | 1994 | 2003 | 25.7 | low | 1 | 0 | 2 | 1 | 0 | 0 |
| Carcinoma, Non-Small Cell Lung | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Carcinoma, Non-Small-Cell Lung | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Carcinoma, Squamous Cell | 0 | | 1994 | 2003 | 25.7 | low | 1 | 0 | 2 | 1 | 0 | 0 |
| Cardiovascular Stroke | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Central Nervous System Cysts | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Central Nervous System Neoplasm | 0 | | 2010 | 2020 | 8.0 | low | 0 | 0 | 0 | 1 | 2 | 0 |
| Central Nervous System Neoplasms | 0 | | 2010 | 2020 | 8.0 | low | 0 | 0 | 0 | 1 | 2 | 0 |
| Central Nervous System Toxoplasmosis | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Cerebral Hemorrhage | 0 | | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Cerebral Infarction | 0 | | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Chronic Kidney Failure | 0 | | 2006 | 2006 | 18.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| Clinically Isolated CNS Demyelinating Syndrome | 0 | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Coin Lesion, Pulmonary | 0 | | 2004 | 2008 | 18.0 | low | 1 | 0 | 0 | 2 | 0 | 0 |
| Craniopharyngioma | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Craniopharyngioma, Adamantinous | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Demyelinating Diseases | 0 | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Diffuse Large B-Cell Lymphoma | 0 | | 2012 | 2023 | 8.3 | low | 0 | 0 | 0 | 0 | 2 | 1 |
| Diffuse Mixed Small and Large Cell Lymphoma | 0 | | 1995 | 2002 | 25.5 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| Disease Exacerbation | 0 | | 2002 | 2014 | 14.5 | low | 1 | 0 | 0 | 2 | 2 | 0 |
| Dysembryoma | 0 | | 2009 | 2020 | 9.5 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| Ear Neoplasms | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Encephalitis | 0 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| Encephalitis, JC Polyomavirus | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Endodermal Sinus Tumor | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Endometrial Neoplasms | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Ependymoma | 0 | | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Epilepsy | 0 | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Experimental Neoplasms | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Fever of Unknown Origin | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Genetic Predisposition | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Germinoblastoma | 0 | | 1994 | 2010 | 22.0 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| Germinoma | 0 | | 2003 | 2022 | 11.5 | low | 0 | 0 | 0 | 1 | 0 | 1 |
| Glial Cell Tumors | 0 | | 1996 | 2022 | 12.0 | low | 4 | 0 | 3 | 11 | 22 | 4 |
| Glioblastoma | 0 | | 1996 | 2023 | 11.9 | low | 3 | 0 | 2 | 1 | 6 | 3 |
| Glioblastoma with Sarcomatous Component | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Glioma | 0 | | 1996 | 2022 | 12.0 | low | 4 | 0 | 3 | 11 | 22 | 4 |
| Gliosarcoma | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Granuloma | 0 | | 2004 | 2011 | 16.5 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| Granulomas | 0 | | 2004 | 2011 | 16.5 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| Granulomatosis, Lymphomatoid | 0 | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| Group A Strep Infection | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Head and Neck Neoplasms | 0 | | 1998 | 2006 | 23.0 | low | 1 | 0 | 2 | 1 | 0 | 0 |
| Headache | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Hematoma | 0 | | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| HIV Coinfection | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| HIV Infections | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Hyperparathyroidism | 0 | | 1996 | 2015 | 16.4 | low | 3 | 0 | 1 | 3 | 3 | 0 |
| Hyperparathyroidism, Primary | 0 | | 2010 | 2023 | 5.8 | low | 0 | 0 | 0 | 1 | 2 | 3 |
| Hyperparathyroidism, Secondary | 0 | | 2004 | 2005 | 19.5 | low | 1 | 0 | 0 | 2 | 0 | 0 |
| Hyperplasia | 0 | | 1996 | 2015 | 16.7 | low | 0 | 0 | 1 | 0 | 2 | 0 |
| Hyperthyroid | 0 | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Hyperthyroidism | 0 | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Hypertrophy | 0 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Hypopharyngeal Cancer | 0 | | 2003 | 2003 | 21.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| Hypopharyngeal Neoplasms | 0 | | 2003 | 2003 | 21.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| Infarct, Lacunar | 0 | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Injuries, Radiation | 0 | | 1996 | 2019 | 18.4 | low | 2 | 0 | 2 | 1 | 2 | 0 |
| Invasiveness, Neoplasm | 0 | | 2005 | 2010 | 16.5 | low | 1 | 0 | 0 | 2 | 0 | 0 |
| Kahler Disease | 0 | | 2015 | 2020 | 6.5 | low | 0 | 0 | 0 | 0 | 4 | 0 |
| Kidney Failure, Chronic | 0 | | 2006 | 2006 | 18.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| Language Disorders | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Laryngeal Neoplasms | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Leukoencephalopathy, Progressive Multifocal | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Local Neoplasm Recurrence | 0 | | 1996 | 2020 | 17.0 | low | 1 | 0 | 3 | 3 | 4 | 0 |
| Lung Neoplasms | 0 | | 1995 | 2009 | 22.8 | low | 1 | 0 | 5 | 3 | 0 | 0 |
| Lymph Node Metastasis | 0 | | 1995 | 2000 | 25.5 | low | 0 | 0 | 4 | 0 | 0 | 0 |
| Lymphatic Diseases | 0 | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Lymphoma | 0 | | 1994 | 2010 | 22.0 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| Lymphoma, AIDS-Related | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Lymphoma, Large B-Cell, Diffuse | 0 | | 2012 | 2023 | 8.3 | low | 0 | 0 | 0 | 0 | 2 | 1 |
| Lymphoma, Non-Hodgkin | 0 | | 1995 | 2002 | 25.5 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| Malignant Melanoma | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Mediastinal Neoplasms | 0 | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Melanoma | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Memory Disorders | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Meningeal Neoplasms | 0 | | 1996 | 2013 | 17.0 | low | 0 | 0 | 1 | 0 | 2 | 0 |
| Meningioma | 0 | | 1996 | 2013 | 19.5 | low | 0 | 0 | 1 | 0 | 1 | 0 |
| Meningitis | 0 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Minimal Disease, Residual | 0 | | 1996 | 2018 | 17.0 | low | 1 | 0 | 1 | 0 | 1 | 0 |
| Morbid Obesity | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| MS (Multiple Sclerosis) | 0 | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Multiple Myeloma | 0 | | 2015 | 2020 | 6.5 | low | 0 | 0 | 0 | 0 | 4 | 0 |
| Multiple Primary Neoplasms | 0 | | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Multiple Sclerosis | 0 | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Myocardial Infarction | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Nausea | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Necrosis | 0 | | 1996 | 2019 | 16.5 | low | 2 | 0 | 1 | 1 | 2 | 0 |
| Neoplasm Metastasis, Unknown Primary | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Neoplasms | 0 | | 2001 | 2023 | 12.0 | low | 0 | 0 | 0 | 1 | 2 | 1 |
| Neoplasms, Germ Cell and Embryonal | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Neoplasms, Neuroepithelial | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Neoplasms, Plasma Cell | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Neoplasms, Skull Base | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Neurocytoma | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Obesity, Morbid | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Oligodendroglioma | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| Orphan Diseases | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Ovarian Neoplasms | 0 | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Pachymeningitis | 0 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Parathyroid Diseases | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Parathyroid Disorders | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Parathyroid Neoplasms | 0 | | 1996 | 2023 | 13.2 | low | 0 | 0 | 1 | 4 | 7 | 1 |
| Pituitary ACTH Hypersecretion | 0 | | 2023 | 2023 | 1.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| Pituitary Neoplasms | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Primary Hyperparathyroidism | 0 | | 2010 | 2023 | 5.8 | low | 0 | 0 | 0 | 1 | 2 | 3 |
| Pulmonary Sarcoidosis | 0 | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Recrudescence | 0 | | 2010 | 2021 | 9.0 | low | 1 | 0 | 0 | 1 | 7 | 1 |
| Rectal Neoplasms | 0 | | 2002 | 2002 | 22.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| Rhabdoid Tumor | 0 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Sarcoidosis | 0 | | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Sarcoidosis, Pulmonary | 0 | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Secondary Hyperparathyroidism | 0 | | 2004 | 2005 | 19.5 | low | 1 | 0 | 0 | 2 | 0 | 0 |
| Seizures | 0 | | 1998 | 2022 | 14.0 | low | 0 | 0 | 1 | 0 | 0 | 1 |
| Sensitivity and Specificity | 0 | | 1996 | 2021 | 16.2 | low | 11 | 0 | 7 | 20 | 11 | 2 |
| Skin Neoplasms | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Soft Tissue Neoplasms | 0 | | 1996 | 2009 | 21.5 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| Sparganosis | 0 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Streptococcal Infections | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Teratoma | 0 | | 2009 | 2020 | 9.5 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| Toxoplasmosis, Cerebral | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Uterine Cervical Neoplasms | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Yolk Sac Tumor | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Diagnostic utility of Clinical endocrinology, , Volume: 99, Issue:3, 2023
Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?World journal of surgery, , Volume: 41, Issue:4, 2017
A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia.Nuclear medicine communications, , Volume: 36, Issue:1, 2015
11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.Nuklearmedizin. Nuclear medicine, , Volume: 54, Issue:1, 2015
Hyperparathyroidism caused by retroesophageal adenoma located with C-11 methionine PET/CT in a morbidly obese patient.Surgery, , Volume: 157, Issue:1, 2015
Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT.Annals of surgery, , Volume: 257, Issue:6, 2013
Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia.Diagnostic and interventional radiology (Ankara, Turkey), , Volume: 17, Issue:4, 2011
C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, , Volume: 42, Issue:3, 2010
Localization of parathyroid adenomas using 11C-methionine positron emission tomography.Nuclear medicine communications, , Volume: 26, Issue:2, 2005
C-11 methionine uptake in granulomatous disease.Clinical nuclear medicine, , Volume: 29, Issue:9, 2004
Use of co-registered 11C-methionine PET and computed tomography for the localisation of parathyroid adenomas.European journal of nuclear medicine and molecular imaging, , Volume: 30, Issue:11, 2003
PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:11, 1996
Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism.Revista espanola de medicina nuclear e imagen molecular, , Volume: 33, Issue:2
Diagnostic Performance of [World neurosurgery, , Volume: 148, 2021
[Lacunar stroke as a very late complication of radiotherapy: value of nuclear medicine techniques].Revista de neurologia, , Dec-16, Volume: 71, Issue:12, 2020
[Utility of 11C-methionine PET/CT in neuro-oncology].Medicina, , Volume: 73, Issue:3, 2013
Monitoring the effect of chemotherapy in a mixed glioma by C-11-methionine PET.Journal of neuroimaging : official journal of the American Society of Neuroimaging, , Volume: 13, Issue:3, 2003
A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.European journal of nuclear medicine, , Volume: 25, Issue:9, 1998
Delayed cerebral radionecrosis with a high uptake of 11C-methionine on positron emission tomography and 201Tl-chloride on single-photon emission computed tomography.Neuroradiology, , Volume: 40, Issue:7, 1998
Three-dimensional imaging of cortical structure, function and glioma for tumor resection.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 38, Issue:10, 1997
Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy.European journal of nuclear medicine, , Volume: 23, Issue:5, 1996
Serial positron emission tomography imaging of changes in amino acid metabolism in low grade astrocytoma after radio- and chemotherapy-- Case report.Neurologia medico-chirurgica, , Volume: 35, Issue:11, 1995
11C-methionine PET/MRI in postoperative patients after craniotomy: zero echo time and head atlas versus CT-based attenuation correction.The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., , Volume: 67, Issue:3, 2023
The role of optimal cut-off diagnosis in 11C-methionine PET for differentiation of intracranial brain tumor from non-neoplastic lesions before treatment.Clinical imaging, , Volume: 92, 2022
Diverse Patterns and Clinical Significance of 11C-Methionine PET in Dysembryoplastic Neuroepithelial Tumors.Clinical nuclear medicine, , Dec-01, Volume: 47, Issue:12, 2022
Value of C-11 methionine PET/CT in patients with intracranial germinoma.PloS one, , Volume: 17, Issue:2, 2022
Prediction of Glioma Stemlike Cell Infiltration in the Non-Contrast-Enhancing Area by Quantitative Measurement of Lactate on Magnetic Resonance Spectroscopy in Glioblastoma.World neurosurgery, , Volume: 153, 2021
Persistent Nontumoral High-Amino-Acid Uptake on Brain [11C]Methionine PET/CT in a Patient After Combined Glioma Treatment.Clinical nuclear medicine, , Jul-01, Volume: 46, Issue:7, 2021
Diagnostic Performance of [World neurosurgery, , Volume: 148, 2021
Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience.Clinical nuclear medicine, , Volume: 46, Issue:1, 2021
[Lacunar stroke as a very late complication of radiotherapy: value of nuclear medicine techniques].Revista de neurologia, , Dec-16, Volume: 71, Issue:12, 2020
The role of 11C-methionine PET in patients with negative diffusion-weighted magnetic resonance imaging: correlation with histology and molecular biomarkers in operated gliomas.Nuclear medicine communications, , Volume: 41, Issue:7, 2020
Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors.World neurosurgery, , Volume: 126, 2019
Combination of Magnetic Resonance Spectroscopy and ¹¹C-Methionine Positron Emission Tomography for the Accurate Diagnosis of Non-Enhancing Supratentorial Glioma.Korean journal of radiology, , Volume: 20, Issue:6, 2019
The Application of Magnetic Resonance Imaging-Deformed 11C-Methionine-Positron Emission Tomography Images in Stereotactic Radiosurgery.Stereotactic and functional neurosurgery, , Volume: 97, Issue:4, 2019
11C-methionine-PET for differentiating recurrent brain tumor from radiation necrosis: radiomics approach with random forest classifier.Scientific reports, , 10-30, Volume: 9, Issue:1, 2019
Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography.European radiology, , Volume: 28, Issue:8, 2018
Diagnostic accuracy of Annals of nuclear medicine, , Volume: 32, Issue:2, 2018
Glioma Survival Prediction with Combined Analysis of In Vivo Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 59, Issue:6, 2018
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas.Neuro-oncology, , 02-19, Volume: 20, Issue:3, 2018
An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using Annals of nuclear medicine, , Volume: 31, Issue:3, 2017
Value of the visual and semiquantitative analysis of carbon-11-methionine PET/CT in brain tumors' recurrence versus post-therapeutic changes.Nuclear medicine communications, , Volume: 38, Issue:12, 2017
Comparison of diffusion tensor imaging and Journal of neurosurgery, , Volume: 125, Issue:5, 2016
Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.European journal of nuclear medicine and molecular imaging, , Volume: 42, Issue:7, 2015
A meta-analysis on the diagnostic performance of (18)F-FDG and (11)C-methionine PET for differentiating brain tumors.AJNR. American journal of neuroradiology, , Volume: 35, Issue:6, 2014
Value of 11C-methionine PET in imaging brain tumours and metastases.European journal of nuclear medicine and molecular imaging, , Volume: 40, Issue:4, 2013
[Utility of 11C-methionine PET/CT in neuro-oncology].Medicina, , Volume: 73, Issue:3, 2013
Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma.Clinical cancer research : an official journal of the American Association for Cancer Research, , Jan-01, Volume: 18, Issue:1, 2012
Evaluation of brain tumors using dynamic 11C-methionine-PET.Journal of neuro-oncology, , Volume: 109, Issue:1, 2012
A pitfall of C-11 methionine PET: cerebral venous infarction mimicked a glioma.Clinical nuclear medicine, , Volume: 37, Issue:1, 2012
Assessment of rhabdoid brain tumor by F-18 FDG PET, C-11 methionine PET and MRI.Clinical nuclear medicine, , Volume: 37, Issue:2, 2012
F-18 FDG and C-11 methionine PET/CT in intracranial dural metastases.Clinical nuclear medicine, , Volume: 37, Issue:2, 2012
Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors.Clinical nuclear medicine, , Volume: 37, Issue:2, 2012
Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.International journal of radiation oncology, biology, physics, , Jan-01, Volume: 82, Issue:1, 2012
Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.European journal of nuclear medicine and molecular imaging, , Volume: 38, Issue:3, 2011
Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions.Annals of nuclear medicine, , Volume: 25, Issue:3, 2011
Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 52, Issue:6, 2011
Comparison of C-11 methionine and C-11 choline for PET imaging of brain metastases: a prospective pilot study.Clinical nuclear medicine, , Volume: 36, Issue:8, 2011
Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.International journal of radiation oncology, biology, physics, , Feb-01, Volume: 73, Issue:2, 2009
Target definition by C11-methionine-PET for the radiotherapy of brain metastases.International journal of radiation oncology, biology, physics, , Jul-01, Volume: 74, Issue:3, 2009
Use of fractional anisotropy for determination of the cut-off value in 11C-methionine positron emission tomography for glioma.NeuroImage, , Apr-01, Volume: 45, Issue:2, 2009
Carbon 11-labeled methionine positron emission tomography for detection of residual viable tumor cells after adjuvant therapy in nongerminomatous malignant germ cell tumors in 2 cases including an autopsy case.Surgical neurology, , Volume: 71, Issue:1, 2009
Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine?European journal of nuclear medicine and molecular imaging, , Volume: 34, Issue:12, 2007
Integration of [11C]methionine-positron emission tomographic and magnetic resonance imaging for image-guided surgical resection of infiltrative low-grade brain tumors in children.Neurosurgery, , Volume: 57, Issue:1 Suppl, 2005
Functional imaging of a large demyelinating lesion.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, , Volume: 12, Issue:2, 2005
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.European journal of nuclear medicine and molecular imaging, , Volume: 32, Issue:1, 2005
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.European journal of nuclear medicine and molecular imaging, , Volume: 32, Issue:1, 2005
Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.Annals of nuclear medicine, , Volume: 19, Issue:8, 2005
Methionine and glucose metabolism of central neurocytoma: a PET study.Clinical nuclear medicine, , Volume: 29, Issue:12, 2004
Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.Annals of nuclear medicine, , Volume: 18, Issue:4, 2004
Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 45, Issue:8, 2004
Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine.European journal of nuclear medicine and molecular imaging, , Volume: 30, Issue:11, 2003
High uptake on 11C-methionine positron emission tomographic scan of basal ganglia germinoma with cerebral hemiatrophy.AJNR. American journal of neuroradiology, , Volume: 24, Issue:9, 2003
Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.Journal of neurosurgery, , Volume: 99, Issue:3, 2003
Monitoring the effect of chemotherapy in a mixed glioma by C-11-methionine PET.Journal of neuroimaging : official journal of the American Society of Neuroimaging, , Volume: 13, Issue:3, 2003
Imaging gliomas with positron emission tomography and single-photon emission computed tomography.Seminars in nuclear medicine, , Volume: 33, Issue:2, 2003
Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas.European journal of nuclear medicine and molecular imaging, , Volume: 29, Issue:5, 2002
Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors.Journal of neurosurgery, , Volume: 91, Issue:5, 1999
Short-term memory deficit after focal parietal damage.Journal of clinical and experimental neuropsychology, , Volume: 21, Issue:6, 1999
Crossed cerebellar diaschisis and brain tumor biochemistry studied with positron emission tomography, [18F]fluorodeoxyglucose and [11C]methionine.Journal of the neurological sciences, , Volume: 156, Issue:1, 1998
Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:5, 1998
A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.European journal of nuclear medicine, , Volume: 25, Issue:9, 1998
Delayed cerebral radionecrosis with a high uptake of 11C-methionine on positron emission tomography and 201Tl-chloride on single-photon emission computed tomography.Neuroradiology, , Volume: 40, Issue:7, 1998
Three-dimensional imaging of cortical structure, function and glioma for tumor resection.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 38, Issue:10, 1997
PET scanning and the human immunodeficiency virus-positive patient.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 38, Issue:10, 1997
C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.Clinical nuclear medicine, , Volume: 21, Issue:7, 1996
Hyperperfusion and hypermetabolism in brain radiation necrosis with epileptic activity.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:7, 1996
F-Dopa as an amino acid tracer to detect brain tumors.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:7, 1996
Serial positron emission tomography imaging of changes in amino acid metabolism in low grade astrocytoma after radio- and chemotherapy-- Case report.Neurologia medico-chirurgica, , Volume: 35, Issue:11, 1995
Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain.Radiographics : a review publication of the Radiological Society of North America, Inc, , Volume: 14, Issue:1, 1994
(11)C-Methionine uptake in secondary brain epilepsy.Revista espanola de medicina nuclear e imagen molecular, , Volume: 33, Issue:4
The demonstration of extension of high-grade glioma beyond magnetic resonance imaging defined edema by the use of (11) C-methionine positron emission tomography.Journal of cancer research and therapeutics, , Volume: 9, Issue:4
Preliminary study of carbon-11 methionine PET in the evaluation of early response to therapy in advanced breast cancer.Nuclear medicine communications, , Volume: 30, Issue:1, 2009
Target definition by C11-methionine-PET for the radiotherapy of brain metastases.International journal of radiation oncology, biology, physics, , Jul-01, Volume: 74, Issue:3, 2009
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:9, 1996
Early response to chemotherapy in hypopharyngeal cancer: assessment with (11)C-methionine PET, correlation with morphologic response, and clinical outcome.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 44, Issue:4, 2003
Carbon-11-methionine uptake in squamous cell head and neck cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:8, 1998
Imaging of uterine carcinoma by carbon-11-methionine and PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 35, Issue:10, 1994
(11)C-Methionine positron emission tomography may monitor the activity of encephalitis.Acta radiologica (Stockholm, Sweden : 1987), , Dec-01, Volume: 53, Issue:10, 2012
18F-FDG and 11C-methionine PET/CT findings in a case with anti-NMDA (NR2B) receptor encephalitis.Clinical nuclear medicine, , Volume: 37, Issue:4, 2012
The Assessment of Glioblastoma Metabolic Activity via 11C-Methionine PET and Radiomics.Studies in health technology and informatics, , May-18, Volume: 302, 2023
Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma.PloS one, , Volume: 17, Issue:2, 2022
Prediction of Glioma Stemlike Cell Infiltration in the Non-Contrast-Enhancing Area by Quantitative Measurement of Lactate on Magnetic Resonance Spectroscopy in Glioblastoma.World neurosurgery, , Volume: 153, 2021
C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.International journal of radiation oncology, biology, physics, , 11-15, Volume: 102, Issue:4, 2018
Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.International journal of radiation oncology, biology, physics, , Jan-01, Volume: 82, Issue:1, 2012
Differentiation of newly diagnosed glioblastoma multiforme and intracranial diffuse large B-cell Lymphoma using (11)C-methionine and (18)F-FDG PET.Clinical nuclear medicine, , Volume: 37, Issue:9, 2012
Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma.Clinical cancer research : an official journal of the American Association for Cancer Research, , Jan-01, Volume: 18, Issue:1, 2012
Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 52, Issue:6, 2011
Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.European journal of nuclear medicine and molecular imaging, , Volume: 38, Issue:3, 2011
Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.International journal of radiation oncology, biology, physics, , Feb-01, Volume: 73, Issue:2, 2009
A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.European journal of nuclear medicine, , Volume: 25, Issue:9, 1998
C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.Clinical nuclear medicine, , Volume: 21, Issue:7, 1996
Diverse Patterns and Clinical Significance of 11C-Methionine PET in Dysembryoplastic Neuroepithelial Tumors.Clinical nuclear medicine, , Dec-01, Volume: 47, Issue:12, 2022
Persistent Nontumoral High-Amino-Acid Uptake on Brain [11C]Methionine PET/CT in a Patient After Combined Glioma Treatment.Clinical nuclear medicine, , Jul-01, Volume: 46, Issue:7, 2021
Diagnostic Performance of [World neurosurgery, , Volume: 148, 2021
Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience.Clinical nuclear medicine, , Volume: 46, Issue:1, 2021
The role of 11C-methionine PET in patients with negative diffusion-weighted magnetic resonance imaging: correlation with histology and molecular biomarkers in operated gliomas.Nuclear medicine communications, , Volume: 41, Issue:7, 2020
Hypoxia and Amino Acid Imaging of High-Grade Glioma: 18F-FAZA PET/CT and 11C-Methionine PET/MRI.Clinical nuclear medicine, , Volume: 45, Issue:6, 2020
Histogram analysis of 11C-methionine integrated PET/MRI may facilitate to determine the O6-methylguanylmethyltransferase methylation status in gliomas.Nuclear medicine communications, , Volume: 40, Issue:8, 2019
Combination of Magnetic Resonance Spectroscopy and ¹¹C-Methionine Positron Emission Tomography for the Accurate Diagnosis of Non-Enhancing Supratentorial Glioma.Korean journal of radiology, , Volume: 20, Issue:6, 2019
Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors.World neurosurgery, , Volume: 126, 2019
Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography.European radiology, , Volume: 28, Issue:8, 2018
Discrimination between primary low-grade and high-grade glioma with The British journal of radiology, , Volume: 91, Issue:1082, 2018
Glioma Survival Prediction with Combined Analysis of In Vivo Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 59, Issue:6, 2018
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas.Neuro-oncology, , 02-19, Volume: 20, Issue:3, 2018
An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using Annals of nuclear medicine, , Volume: 31, Issue:3, 2017
Comparison of diffusion tensor imaging and Journal of neurosurgery, , Volume: 125, Issue:5, 2016
Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.European journal of nuclear medicine and molecular imaging, , Volume: 42, Issue:7, 2015
¹⁸F-fluorodeoxyglucose and ¹¹C-methionine positron emission tomography in relation to methyl-guanine methyltransferase promoter methylation in high-grade gliomas.Nuclear medicine communications, , Volume: 36, Issue:3, 2015
Correlation of 11C-methionine PET and diffusion-weighted MRI: is there a complementary diagnostic role for gliomas?Nuclear medicine communications, , Volume: 35, Issue:7, 2014
[Utility of 11C-methionine PET/CT in neuro-oncology].Medicina, , Volume: 73, Issue:3, 2013
Detection of glioma recurrence by ¹¹C-methionine positron emission tomography and dynamic susceptibility contrast-enhanced magnetic resonance imaging: a meta-analysis.Nuclear medicine communications, , Volume: 34, Issue:8, 2013
Value of 11C-methionine PET in imaging brain tumours and metastases.European journal of nuclear medicine and molecular imaging, , Volume: 40, Issue:4, 2013
A pitfall of C-11 methionine PET: cerebral venous infarction mimicked a glioma.Clinical nuclear medicine, , Volume: 37, Issue:1, 2012
Quantitative volumetric analysis of gliomas with sequential MRI and ¹¹C-methionine PET assessment: patterns of integration in therapy planning.European journal of nuclear medicine and molecular imaging, , Volume: 39, Issue:5, 2012
A novel PET index, 18F-FDG-11C-methionine uptake decoupling score, reflects glioma cell infiltration.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 53, Issue:11, 2012
11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 53, Issue:11, 2012
Use of positron emission tomography in the evaluation of diffuse intrinsic brainstem gliomas in children.Journal of pediatric hematology/oncology, , Volume: 33, Issue:5, 2011
[Usability of 11C-methionine PET in diagnosis of glioma].Gan to kagaku ryoho. Cancer & chemotherapy, , Volume: 37, Issue:6, 2010
Use of fractional anisotropy for determination of the cut-off value in 11C-methionine positron emission tomography for glioma.NeuroImage, , Apr-01, Volume: 45, Issue:2, 2009
Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine?European journal of nuclear medicine and molecular imaging, , Volume: 34, Issue:12, 2007
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas.European journal of nuclear medicine and molecular imaging, , Volume: 33, Issue:5, 2006
Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.Annals of nuclear medicine, , Volume: 19, Issue:8, 2005
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.European journal of nuclear medicine and molecular imaging, , Volume: 32, Issue:1, 2005
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.European journal of nuclear medicine and molecular imaging, , Volume: 32, Issue:1, 2005
Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 45, Issue:8, 2004
Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.Annals of nuclear medicine, , Volume: 18, Issue:4, 2004
Imaging gliomas with positron emission tomography and single-photon emission computed tomography.Seminars in nuclear medicine, , Volume: 33, Issue:2, 2003
Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.Journal of neurosurgery, , Volume: 99, Issue:3, 2003
Crossed cerebellar diaschisis and brain tumor biochemistry studied with positron emission tomography, [18F]fluorodeoxyglucose and [11C]methionine.Journal of the neurological sciences, , Volume: 156, Issue:1, 1998
Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:5, 1998
F-Dopa as an amino acid tracer to detect brain tumors.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:7, 1996
The demonstration of extension of high-grade glioma beyond magnetic resonance imaging defined edema by the use of (11) C-methionine positron emission tomography.Journal of cancer research and therapeutics, , Volume: 9, Issue:4
Individual radiation response of parotid glands investigated by dynamic 11C-methionine PET.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, , Volume: 78, Issue:3, 2006
Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, , Volume: 52, Issue:3, 1999
Carbon-11-methionine uptake in squamous cell head and neck cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:8, 1998
Hyperparathyroidism caused by retroesophageal adenoma located with C-11 methionine PET/CT in a morbidly obese patient.Surgery, , Volume: 157, Issue:1, 2015
18F-FDG PET rarely provides additional information to 11C-methionine PET imaging in hyperparathyroidism.Clinical nuclear medicine, , Volume: 39, Issue:3, 2014
Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 54, Issue:5, 2013
11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis.European journal of nuclear medicine and molecular imaging, , Volume: 33, Issue:4, 2006
11C-methionine PET versus 99mTc-sestamibi in the pre-operative localisation of hyperfunctional parathyroid tissue.European journal of nuclear medicine and molecular imaging, , Volume: 32, Issue:4, 2005
Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET.European journal of nuclear medicine and molecular imaging, , Volume: 31, Issue:10, 2004
PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:11, 1996
A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia.Nuclear medicine communications, , Volume: 36, Issue:1, 2015
Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia.Diagnostic and interventional radiology (Ankara, Turkey), , Volume: 17, Issue:4, 2011
PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:11, 1996
Target definition by C11-methionine-PET for the radiotherapy of brain metastases.International journal of radiation oncology, biology, physics, , Jul-01, Volume: 74, Issue:3, 2009
The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.Annals of nuclear medicine, , Volume: 22, Issue:6, 2008
18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy.Annals of nuclear medicine, , Volume: 18, Issue:8, 2004
Usefulness of PET with 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 41, Issue:2, 2000
Can 11C-methionine play a role in lung cancer staging?Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 41, Issue:2, 2000
Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:4, 1998
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:9, 1996
Carbon-11-methionine PET imaging of malignant melanoma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 36, Issue:10, 1995
[Comparative analysis of the informative value of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography in the differential diagnosis of solitary lung masses].Vestnik rentgenologii i radiologii, , Issue:3
Analysis of progression and recurrence of meningioma using (11)C-methionine PET.Annals of nuclear medicine, , Volume: 27, Issue:8, 2013
F-18 FDG and C-11 methionine PET/CT in intracranial dural metastases.Clinical nuclear medicine, , Volume: 37, Issue:2, 2012
C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.Clinical nuclear medicine, , Volume: 21, Issue:7, 1996
Incidental Finding of an Ovarian Carcinoid on 11C-Methionine PET/CT.Clinical nuclear medicine, , Volume: 45, Issue:11, 2020
[PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients].Terapevticheskii arkhiv, , Jul-15, Volume: 91, Issue:7, 2019
11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement.Theranostics, , Volume: 6, Issue:2, 2016
11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma.Oncotarget, , Apr-10, Volume: 6, Issue:10, 2015
11C-methionine-PET for differentiating recurrent brain tumor from radiation necrosis: radiomics approach with random forest classifier.Scientific reports, , 10-30, Volume: 9, Issue:1, 2019
Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions.Annals of nuclear medicine, , Volume: 25, Issue:3, 2011
Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.Annals of nuclear medicine, , Volume: 18, Issue:4, 2004
Hyperperfusion and hypermetabolism in brain radiation necrosis with epileptic activity.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:7, 1996
Clinical decision-making based on 11C-methionine PET in recurrent Cushing's disease with equivocal MRI findings.Journal of neurosurgery, , Dec-01, Volume: 139, Issue:6, 2023
Evaluation of the biodistribution of 11C-methionine in children and young adults.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 54, Issue:11, 2013
Dynamic 11C-methionine PET analysis has an additional value for differentiating malignant tumors from granulomas: an experimental study using small animal PET.European journal of nuclear medicine and molecular imaging, , Volume: 38, Issue:10, 2011
From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology.Annals of nuclear medicine, , Volume: 15, Issue:6, 2001
Diagnostic utility of Clinical endocrinology, , Volume: 99, Issue:3, 2023
Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?World journal of surgery, , Volume: 41, Issue:4, 2017
11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.Nuklearmedizin. Nuclear medicine, , Volume: 54, Issue:1, 2015
Hyperparathyroidism caused by retroesophageal adenoma located with C-11 methionine PET/CT in a morbidly obese patient.Surgery, , Volume: 157, Issue:1, 2015
A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia.Nuclear medicine communications, , Volume: 36, Issue:1, 2015
18F-FDG PET rarely provides additional information to 11C-methionine PET imaging in hyperparathyroidism.Clinical nuclear medicine, , Volume: 39, Issue:3, 2014
Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT.Annals of surgery, , Volume: 257, Issue:6, 2013
Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia.Diagnostic and interventional radiology (Ankara, Turkey), , Volume: 17, Issue:4, 2011
C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, , Volume: 42, Issue:3, 2010
Localization of parathyroid adenomas using 11C-methionine positron emission tomography.Nuclear medicine communications, , Volume: 26, Issue:2, 2005
C-11 methionine uptake in granulomatous disease.Clinical nuclear medicine, , Volume: 29, Issue:9, 2004
Use of co-registered 11C-methionine PET and computed tomography for the localisation of parathyroid adenomas.European journal of nuclear medicine and molecular imaging, , Volume: 30, Issue:11, 2003
PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:11, 1996
Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism.Revista espanola de medicina nuclear e imagen molecular, , Volume: 33, Issue:2
Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomas.Molecular imaging and biology, , Volume: 11, Issue:5
Diverse Patterns and Clinical Significance of 11C-Methionine PET in Dysembryoplastic Neuroepithelial Tumors.Clinical nuclear medicine, , Dec-01, Volume: 47, Issue:12, 2022
Carbon-11-methionine PET in focal cortical dysplasia: a comparison with fluorine-18-FDG PET and technetium-99m-ECD SPECT.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:6, 1998
Diagnostic Performance of [World neurosurgery, , Volume: 148, 2021
[no title available]Annals of nuclear medicine, , Volume: 35, Issue:4, 2021
Combination of Magnetic Resonance Spectroscopy and ¹¹C-Methionine Positron Emission Tomography for the Accurate Diagnosis of Non-Enhancing Supratentorial Glioma.Korean journal of radiology, , Volume: 20, Issue:6, 2019
Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors.World neurosurgery, , Volume: 126, 2019
Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, , Volume: 44, Issue:2, 2019
[PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients].Terapevticheskii arkhiv, , Jul-15, Volume: 91, Issue:7, 2019
Discrimination between primary low-grade and high-grade glioma with The British journal of radiology, , Volume: 91, Issue:1082, 2018
Diagnostic accuracy of Annals of nuclear medicine, , Volume: 32, Issue:2, 2018
11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.Nuklearmedizin. Nuclear medicine, , Volume: 54, Issue:1, 2015
A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia.Nuclear medicine communications, , Volume: 36, Issue:1, 2015
A meta-analysis on the diagnostic performance of (18)F-FDG and (11)C-methionine PET for differentiating brain tumors.AJNR. American journal of neuroradiology, , Volume: 35, Issue:6, 2014
Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT.Annals of surgery, , Volume: 257, Issue:6, 2013
Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.International journal of radiation oncology, biology, physics, , Jan-01, Volume: 82, Issue:1, 2012
Use of fractional anisotropy for determination of the cut-off value in 11C-methionine positron emission tomography for glioma.NeuroImage, , Apr-01, Volume: 45, Issue:2, 2009
Target definition by C11-methionine-PET for the radiotherapy of brain metastases.International journal of radiation oncology, biology, physics, , Jul-01, Volume: 74, Issue:3, 2009
The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.Annals of nuclear medicine, , Volume: 22, Issue:6, 2008
Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine?European journal of nuclear medicine and molecular imaging, , Volume: 34, Issue:12, 2007
11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis.European journal of nuclear medicine and molecular imaging, , Volume: 33, Issue:4, 2006
Individual radiation response of parotid glands investigated by dynamic 11C-methionine PET.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, , Volume: 78, Issue:3, 2006
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas.European journal of nuclear medicine and molecular imaging, , Volume: 33, Issue:5, 2006
Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.Annals of nuclear medicine, , Volume: 19, Issue:8, 2005
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.European journal of nuclear medicine and molecular imaging, , Volume: 32, Issue:1, 2005
Localization of parathyroid adenomas using 11C-methionine positron emission tomography.Nuclear medicine communications, , Volume: 26, Issue:2, 2005
11C-methionine PET versus 99mTc-sestamibi in the pre-operative localisation of hyperfunctional parathyroid tissue.European journal of nuclear medicine and molecular imaging, , Volume: 32, Issue:4, 2005
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.European journal of nuclear medicine and molecular imaging, , Volume: 32, Issue:1, 2005
18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy.Annals of nuclear medicine, , Volume: 18, Issue:8, 2004
Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET.European journal of nuclear medicine and molecular imaging, , Volume: 31, Issue:10, 2004
Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.Annals of nuclear medicine, , Volume: 18, Issue:4, 2004
Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 45, Issue:8, 2004
Early response to chemotherapy in hypopharyngeal cancer: assessment with (11)C-methionine PET, correlation with morphologic response, and clinical outcome.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 44, Issue:4, 2003
Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine.European journal of nuclear medicine and molecular imaging, , Volume: 30, Issue:11, 2003
Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas.European journal of nuclear medicine and molecular imaging, , Volume: 29, Issue:5, 2002
PET imaging with [11C]methyl- L-methionine for therapy monitoring in patients with rectal cancer.European journal of nuclear medicine and molecular imaging, , Volume: 29, Issue:6, 2002
Usefulness of PET with 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 41, Issue:2, 2000
Can 11C-methionine play a role in lung cancer staging?Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 41, Issue:2, 2000
Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:4, 1998
Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:7, 1998
PET scanning and the human immunodeficiency virus-positive patient.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 38, Issue:10, 1997
PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:11, 1996
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:9, 1996
[Comparative analysis of the informative value of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography in the differential diagnosis of solitary lung masses].Vestnik rentgenologii i radiologii, , Issue:3
18 F-THK5351 PET Can Evaluate Tumor Extension in Intravascular Large B-Cell Lymphoma : Comparison With 11C-Methionine PET and 18F-FDG PET.Clinical nuclear medicine, , Apr-01, Volume: 48, Issue:4, 2023
Differentiation of newly diagnosed glioblastoma multiforme and intracranial diffuse large B-cell Lymphoma using (11)C-methionine and (18)F-FDG PET.Clinical nuclear medicine, , Volume: 37, Issue:9, 2012
(11)C-methionine PET/CT and MRI of primary central nervous system diffuse large B-cell lymphoma before and after high-dose methotrexate.Clinical nuclear medicine, , Volume: 37, Issue:10, 2012
Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma.Japanese journal of clinical oncology, , May-05, Volume: 50, Issue:5, 2020
Discrimination between primary low-grade and high-grade glioma with The British journal of radiology, , Volume: 91, Issue:1082, 2018
Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings.Annals of nuclear medicine, , Volume: 24, Issue:5, 2010
Diagnostic utility of Clinical endocrinology, , Volume: 99, Issue:3, 2023
Head-to-Head Comparison of Tc-99m-sestamibi SPECT/CT and C-11-L-Methionin PET/CT in Parathyroid Scanning Before Operation for Primary Hyperparathyroidism.Molecular imaging and biology, , Volume: 25, Issue:4, 2023
[no title available]Annals of nuclear medicine, , Volume: 35, Issue:4, 2021
Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?World journal of surgery, , Volume: 41, Issue:4, 2017
11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.Nuklearmedizin. Nuclear medicine, , Volume: 54, Issue:1, 2015
C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, , Volume: 42, Issue:3, 2010
Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism.Revista espanola de medicina nuclear e imagen molecular, , Volume: 33, Issue:2
C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.International journal of radiation oncology, biology, physics, , 11-15, Volume: 102, Issue:4, 2018
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:9, 1996
Usefulness of 11C-methionine-positron emission tomography for the diagnosis of progressive multifocal leukoencephalopathy.Journal of neurology, , Volume: 261, Issue:12, 2014
Analysis of progression and recurrence of meningioma using (11)C-methionine PET.Annals of nuclear medicine, , Volume: 27, Issue:8, 2013
Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.International journal of radiation oncology, biology, physics, , Feb-01, Volume: 73, Issue:2, 2009
Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas.European journal of nuclear medicine and molecular imaging, , Volume: 29, Issue:5, 2002
Diagnostic utility of Clinical endocrinology, , Volume: 99, Issue:3, 2023
Head-to-Head Comparison of Tc-99m-sestamibi SPECT/CT and C-11-L-Methionin PET/CT in Parathyroid Scanning Before Operation for Primary Hyperparathyroidism.Molecular imaging and biology, , Volume: 25, Issue:4, 2023
[no title available]Annals of nuclear medicine, , Volume: 35, Issue:4, 2021
Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?World journal of surgery, , Volume: 41, Issue:4, 2017
11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.Nuklearmedizin. Nuclear medicine, , Volume: 54, Issue:1, 2015
C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, , Volume: 42, Issue:3, 2010
Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism.Revista espanola de medicina nuclear e imagen molecular, , Volume: 33, Issue:2
Diagnostic utility of Clinical endocrinology, , Volume: 99, Issue:3, 2023
Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?World journal of surgery, , Volume: 41, Issue:4, 2017
A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia.Nuclear medicine communications, , Volume: 36, Issue:1, 2015
Hyperparathyroidism caused by retroesophageal adenoma located with C-11 methionine PET/CT in a morbidly obese patient.Surgery, , Volume: 157, Issue:1, 2015
11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.Nuklearmedizin. Nuclear medicine, , Volume: 54, Issue:1, 2015
Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT.Annals of surgery, , Volume: 257, Issue:6, 2013
Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia.Diagnostic and interventional radiology (Ankara, Turkey), , Volume: 17, Issue:4, 2011
C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, , Volume: 42, Issue:3, 2010
Localization of parathyroid adenomas using 11C-methionine positron emission tomography.Nuclear medicine communications, , Volume: 26, Issue:2, 2005
C-11 methionine uptake in granulomatous disease.Clinical nuclear medicine, , Volume: 29, Issue:9, 2004
Use of co-registered 11C-methionine PET and computed tomography for the localisation of parathyroid adenomas.European journal of nuclear medicine and molecular imaging, , Volume: 30, Issue:11, 2003
PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:11, 1996
Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism.Revista espanola de medicina nuclear e imagen molecular, , Volume: 33, Issue:2
Diagnostic Performance of [World neurosurgery, , Volume: 148, 2021
[Lacunar stroke as a very late complication of radiotherapy: value of nuclear medicine techniques].Revista de neurologia, , Dec-16, Volume: 71, Issue:12, 2020
[Utility of 11C-methionine PET/CT in neuro-oncology].Medicina, , Volume: 73, Issue:3, 2013
Monitoring the effect of chemotherapy in a mixed glioma by C-11-methionine PET.Journal of neuroimaging : official journal of the American Society of Neuroimaging, , Volume: 13, Issue:3, 2003
Delayed cerebral radionecrosis with a high uptake of 11C-methionine on positron emission tomography and 201Tl-chloride on single-photon emission computed tomography.Neuroradiology, , Volume: 40, Issue:7, 1998
A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.European journal of nuclear medicine, , Volume: 25, Issue:9, 1998
Three-dimensional imaging of cortical structure, function and glioma for tumor resection.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 38, Issue:10, 1997
Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy.European journal of nuclear medicine, , Volume: 23, Issue:5, 1996
Serial positron emission tomography imaging of changes in amino acid metabolism in low grade astrocytoma after radio- and chemotherapy-- Case report.Neurologia medico-chirurgica, , Volume: 35, Issue:11, 1995
11C-methionine PET/MRI in postoperative patients after craniotomy: zero echo time and head atlas versus CT-based attenuation correction.The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., , Volume: 67, Issue:3, 2023
Value of C-11 methionine PET/CT in patients with intracranial germinoma.PloS one, , Volume: 17, Issue:2, 2022
Diverse Patterns and Clinical Significance of 11C-Methionine PET in Dysembryoplastic Neuroepithelial Tumors.Clinical nuclear medicine, , Dec-01, Volume: 47, Issue:12, 2022
The role of optimal cut-off diagnosis in 11C-methionine PET for differentiation of intracranial brain tumor from non-neoplastic lesions before treatment.Clinical imaging, , Volume: 92, 2022
Prediction of Glioma Stemlike Cell Infiltration in the Non-Contrast-Enhancing Area by Quantitative Measurement of Lactate on Magnetic Resonance Spectroscopy in Glioblastoma.World neurosurgery, , Volume: 153, 2021
Diagnostic Performance of [World neurosurgery, , Volume: 148, 2021
Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience.Clinical nuclear medicine, , Volume: 46, Issue:1, 2021
Persistent Nontumoral High-Amino-Acid Uptake on Brain [11C]Methionine PET/CT in a Patient After Combined Glioma Treatment.Clinical nuclear medicine, , Jul-01, Volume: 46, Issue:7, 2021
[Lacunar stroke as a very late complication of radiotherapy: value of nuclear medicine techniques].Revista de neurologia, , Dec-16, Volume: 71, Issue:12, 2020
The role of 11C-methionine PET in patients with negative diffusion-weighted magnetic resonance imaging: correlation with histology and molecular biomarkers in operated gliomas.Nuclear medicine communications, , Volume: 41, Issue:7, 2020
Combination of Magnetic Resonance Spectroscopy and ¹¹C-Methionine Positron Emission Tomography for the Accurate Diagnosis of Non-Enhancing Supratentorial Glioma.Korean journal of radiology, , Volume: 20, Issue:6, 2019
The Application of Magnetic Resonance Imaging-Deformed 11C-Methionine-Positron Emission Tomography Images in Stereotactic Radiosurgery.Stereotactic and functional neurosurgery, , Volume: 97, Issue:4, 2019
11C-methionine-PET for differentiating recurrent brain tumor from radiation necrosis: radiomics approach with random forest classifier.Scientific reports, , 10-30, Volume: 9, Issue:1, 2019
Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors.World neurosurgery, , Volume: 126, 2019
Diagnostic accuracy of Annals of nuclear medicine, , Volume: 32, Issue:2, 2018
Glioma Survival Prediction with Combined Analysis of In Vivo Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 59, Issue:6, 2018
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas.Neuro-oncology, , 02-19, Volume: 20, Issue:3, 2018
Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography.European radiology, , Volume: 28, Issue:8, 2018
Value of the visual and semiquantitative analysis of carbon-11-methionine PET/CT in brain tumors' recurrence versus post-therapeutic changes.Nuclear medicine communications, , Volume: 38, Issue:12, 2017
An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using Annals of nuclear medicine, , Volume: 31, Issue:3, 2017
Comparison of diffusion tensor imaging and Journal of neurosurgery, , Volume: 125, Issue:5, 2016
Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.European journal of nuclear medicine and molecular imaging, , Volume: 42, Issue:7, 2015
A meta-analysis on the diagnostic performance of (18)F-FDG and (11)C-methionine PET for differentiating brain tumors.AJNR. American journal of neuroradiology, , Volume: 35, Issue:6, 2014
[Utility of 11C-methionine PET/CT in neuro-oncology].Medicina, , Volume: 73, Issue:3, 2013
Value of 11C-methionine PET in imaging brain tumours and metastases.European journal of nuclear medicine and molecular imaging, , Volume: 40, Issue:4, 2013
F-18 FDG and C-11 methionine PET/CT in intracranial dural metastases.Clinical nuclear medicine, , Volume: 37, Issue:2, 2012
Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors.Clinical nuclear medicine, , Volume: 37, Issue:2, 2012
Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma.Clinical cancer research : an official journal of the American Association for Cancer Research, , Jan-01, Volume: 18, Issue:1, 2012
Evaluation of brain tumors using dynamic 11C-methionine-PET.Journal of neuro-oncology, , Volume: 109, Issue:1, 2012
Assessment of rhabdoid brain tumor by F-18 FDG PET, C-11 methionine PET and MRI.Clinical nuclear medicine, , Volume: 37, Issue:2, 2012
A pitfall of C-11 methionine PET: cerebral venous infarction mimicked a glioma.Clinical nuclear medicine, , Volume: 37, Issue:1, 2012
Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.International journal of radiation oncology, biology, physics, , Jan-01, Volume: 82, Issue:1, 2012
Comparison of C-11 methionine and C-11 choline for PET imaging of brain metastases: a prospective pilot study.Clinical nuclear medicine, , Volume: 36, Issue:8, 2011
Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 52, Issue:6, 2011
Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.European journal of nuclear medicine and molecular imaging, , Volume: 38, Issue:3, 2011
Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions.Annals of nuclear medicine, , Volume: 25, Issue:3, 2011
Carbon 11-labeled methionine positron emission tomography for detection of residual viable tumor cells after adjuvant therapy in nongerminomatous malignant germ cell tumors in 2 cases including an autopsy case.Surgical neurology, , Volume: 71, Issue:1, 2009
Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.International journal of radiation oncology, biology, physics, , Feb-01, Volume: 73, Issue:2, 2009
Target definition by C11-methionine-PET for the radiotherapy of brain metastases.International journal of radiation oncology, biology, physics, , Jul-01, Volume: 74, Issue:3, 2009
Use of fractional anisotropy for determination of the cut-off value in 11C-methionine positron emission tomography for glioma.NeuroImage, , Apr-01, Volume: 45, Issue:2, 2009
Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine?European journal of nuclear medicine and molecular imaging, , Volume: 34, Issue:12, 2007
Functional imaging of a large demyelinating lesion.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, , Volume: 12, Issue:2, 2005
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.European journal of nuclear medicine and molecular imaging, , Volume: 32, Issue:1, 2005
Integration of [11C]methionine-positron emission tomographic and magnetic resonance imaging for image-guided surgical resection of infiltrative low-grade brain tumors in children.Neurosurgery, , Volume: 57, Issue:1 Suppl, 2005
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.European journal of nuclear medicine and molecular imaging, , Volume: 32, Issue:1, 2005
Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.Annals of nuclear medicine, , Volume: 19, Issue:8, 2005
Methionine and glucose metabolism of central neurocytoma: a PET study.Clinical nuclear medicine, , Volume: 29, Issue:12, 2004
Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.Annals of nuclear medicine, , Volume: 18, Issue:4, 2004
Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 45, Issue:8, 2004
Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine.European journal of nuclear medicine and molecular imaging, , Volume: 30, Issue:11, 2003
High uptake on 11C-methionine positron emission tomographic scan of basal ganglia germinoma with cerebral hemiatrophy.AJNR. American journal of neuroradiology, , Volume: 24, Issue:9, 2003
Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.Journal of neurosurgery, , Volume: 99, Issue:3, 2003
Monitoring the effect of chemotherapy in a mixed glioma by C-11-methionine PET.Journal of neuroimaging : official journal of the American Society of Neuroimaging, , Volume: 13, Issue:3, 2003
Imaging gliomas with positron emission tomography and single-photon emission computed tomography.Seminars in nuclear medicine, , Volume: 33, Issue:2, 2003
Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas.European journal of nuclear medicine and molecular imaging, , Volume: 29, Issue:5, 2002
Short-term memory deficit after focal parietal damage.Journal of clinical and experimental neuropsychology, , Volume: 21, Issue:6, 1999
Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors.Journal of neurosurgery, , Volume: 91, Issue:5, 1999
Delayed cerebral radionecrosis with a high uptake of 11C-methionine on positron emission tomography and 201Tl-chloride on single-photon emission computed tomography.Neuroradiology, , Volume: 40, Issue:7, 1998
Crossed cerebellar diaschisis and brain tumor biochemistry studied with positron emission tomography, [18F]fluorodeoxyglucose and [11C]methionine.Journal of the neurological sciences, , Volume: 156, Issue:1, 1998
Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:5, 1998
A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.European journal of nuclear medicine, , Volume: 25, Issue:9, 1998
Three-dimensional imaging of cortical structure, function and glioma for tumor resection.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 38, Issue:10, 1997
PET scanning and the human immunodeficiency virus-positive patient.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 38, Issue:10, 1997
C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.Clinical nuclear medicine, , Volume: 21, Issue:7, 1996
Hyperperfusion and hypermetabolism in brain radiation necrosis with epileptic activity.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:7, 1996
F-Dopa as an amino acid tracer to detect brain tumors.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:7, 1996
Serial positron emission tomography imaging of changes in amino acid metabolism in low grade astrocytoma after radio- and chemotherapy-- Case report.Neurologia medico-chirurgica, , Volume: 35, Issue:11, 1995
Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain.Radiographics : a review publication of the Radiological Society of North America, Inc, , Volume: 14, Issue:1, 1994
The demonstration of extension of high-grade glioma beyond magnetic resonance imaging defined edema by the use of (11) C-methionine positron emission tomography.Journal of cancer research and therapeutics, , Volume: 9, Issue:4
(11)C-Methionine uptake in secondary brain epilepsy.Revista espanola de medicina nuclear e imagen molecular, , Volume: 33, Issue:4
Target definition by C11-methionine-PET for the radiotherapy of brain metastases.International journal of radiation oncology, biology, physics, , Jul-01, Volume: 74, Issue:3, 2009
Preliminary study of carbon-11 methionine PET in the evaluation of early response to therapy in advanced breast cancer.Nuclear medicine communications, , Volume: 30, Issue:1, 2009
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:9, 1996
Early response to chemotherapy in hypopharyngeal cancer: assessment with (11)C-methionine PET, correlation with morphologic response, and clinical outcome.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 44, Issue:4, 2003
Carbon-11-methionine uptake in squamous cell head and neck cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:8, 1998
Imaging of uterine carcinoma by carbon-11-methionine and PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 35, Issue:10, 1994
The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.Annals of nuclear medicine, , Volume: 22, Issue:6, 2008
18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy.Annals of nuclear medicine, , Volume: 18, Issue:8, 2004
[Comparative analysis of the informative value of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography in the differential diagnosis of solitary lung masses].Vestnik rentgenologii i radiologii, , Issue:3
(11)C-Methionine positron emission tomography may monitor the activity of encephalitis.Acta radiologica (Stockholm, Sweden : 1987), , Dec-01, Volume: 53, Issue:10, 2012
18F-FDG and 11C-methionine PET/CT findings in a case with anti-NMDA (NR2B) receptor encephalitis.Clinical nuclear medicine, , Volume: 37, Issue:4, 2012
The Assessment of Glioblastoma Metabolic Activity via 11C-Methionine PET and Radiomics.Studies in health technology and informatics, , May-18, Volume: 302, 2023
Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma.PloS one, , Volume: 17, Issue:2, 2022
Prediction of Glioma Stemlike Cell Infiltration in the Non-Contrast-Enhancing Area by Quantitative Measurement of Lactate on Magnetic Resonance Spectroscopy in Glioblastoma.World neurosurgery, , Volume: 153, 2021
C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.International journal of radiation oncology, biology, physics, , 11-15, Volume: 102, Issue:4, 2018
Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma.Clinical cancer research : an official journal of the American Association for Cancer Research, , Jan-01, Volume: 18, Issue:1, 2012
Differentiation of newly diagnosed glioblastoma multiforme and intracranial diffuse large B-cell Lymphoma using (11)C-methionine and (18)F-FDG PET.Clinical nuclear medicine, , Volume: 37, Issue:9, 2012
Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.International journal of radiation oncology, biology, physics, , Jan-01, Volume: 82, Issue:1, 2012
Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.European journal of nuclear medicine and molecular imaging, , Volume: 38, Issue:3, 2011
Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 52, Issue:6, 2011
Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.International journal of radiation oncology, biology, physics, , Feb-01, Volume: 73, Issue:2, 2009
A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.European journal of nuclear medicine, , Volume: 25, Issue:9, 1998
C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.Clinical nuclear medicine, , Volume: 21, Issue:7, 1996
Diverse Patterns and Clinical Significance of 11C-Methionine PET in Dysembryoplastic Neuroepithelial Tumors.Clinical nuclear medicine, , Dec-01, Volume: 47, Issue:12, 2022
Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience.Clinical nuclear medicine, , Volume: 46, Issue:1, 2021
Diagnostic Performance of [World neurosurgery, , Volume: 148, 2021
Persistent Nontumoral High-Amino-Acid Uptake on Brain [11C]Methionine PET/CT in a Patient After Combined Glioma Treatment.Clinical nuclear medicine, , Jul-01, Volume: 46, Issue:7, 2021
Hypoxia and Amino Acid Imaging of High-Grade Glioma: 18F-FAZA PET/CT and 11C-Methionine PET/MRI.Clinical nuclear medicine, , Volume: 45, Issue:6, 2020
The role of 11C-methionine PET in patients with negative diffusion-weighted magnetic resonance imaging: correlation with histology and molecular biomarkers in operated gliomas.Nuclear medicine communications, , Volume: 41, Issue:7, 2020
Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors.World neurosurgery, , Volume: 126, 2019
Combination of Magnetic Resonance Spectroscopy and ¹¹C-Methionine Positron Emission Tomography for the Accurate Diagnosis of Non-Enhancing Supratentorial Glioma.Korean journal of radiology, , Volume: 20, Issue:6, 2019
Histogram analysis of 11C-methionine integrated PET/MRI may facilitate to determine the O6-methylguanylmethyltransferase methylation status in gliomas.Nuclear medicine communications, , Volume: 40, Issue:8, 2019
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas.Neuro-oncology, , 02-19, Volume: 20, Issue:3, 2018
Glioma Survival Prediction with Combined Analysis of In Vivo Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 59, Issue:6, 2018
Discrimination between primary low-grade and high-grade glioma with The British journal of radiology, , Volume: 91, Issue:1082, 2018
Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography.European radiology, , Volume: 28, Issue:8, 2018
An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using Annals of nuclear medicine, , Volume: 31, Issue:3, 2017
Comparison of diffusion tensor imaging and Journal of neurosurgery, , Volume: 125, Issue:5, 2016
¹⁸F-fluorodeoxyglucose and ¹¹C-methionine positron emission tomography in relation to methyl-guanine methyltransferase promoter methylation in high-grade gliomas.Nuclear medicine communications, , Volume: 36, Issue:3, 2015
Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.European journal of nuclear medicine and molecular imaging, , Volume: 42, Issue:7, 2015
Correlation of 11C-methionine PET and diffusion-weighted MRI: is there a complementary diagnostic role for gliomas?Nuclear medicine communications, , Volume: 35, Issue:7, 2014
Value of 11C-methionine PET in imaging brain tumours and metastases.European journal of nuclear medicine and molecular imaging, , Volume: 40, Issue:4, 2013
Detection of glioma recurrence by ¹¹C-methionine positron emission tomography and dynamic susceptibility contrast-enhanced magnetic resonance imaging: a meta-analysis.Nuclear medicine communications, , Volume: 34, Issue:8, 2013
[Utility of 11C-methionine PET/CT in neuro-oncology].Medicina, , Volume: 73, Issue:3, 2013
A pitfall of C-11 methionine PET: cerebral venous infarction mimicked a glioma.Clinical nuclear medicine, , Volume: 37, Issue:1, 2012
11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 53, Issue:11, 2012
A novel PET index, 18F-FDG-11C-methionine uptake decoupling score, reflects glioma cell infiltration.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 53, Issue:11, 2012
Quantitative volumetric analysis of gliomas with sequential MRI and ¹¹C-methionine PET assessment: patterns of integration in therapy planning.European journal of nuclear medicine and molecular imaging, , Volume: 39, Issue:5, 2012
Use of positron emission tomography in the evaluation of diffuse intrinsic brainstem gliomas in children.Journal of pediatric hematology/oncology, , Volume: 33, Issue:5, 2011
[Usability of 11C-methionine PET in diagnosis of glioma].Gan to kagaku ryoho. Cancer & chemotherapy, , Volume: 37, Issue:6, 2010
Use of fractional anisotropy for determination of the cut-off value in 11C-methionine positron emission tomography for glioma.NeuroImage, , Apr-01, Volume: 45, Issue:2, 2009
Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine?European journal of nuclear medicine and molecular imaging, , Volume: 34, Issue:12, 2007
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas.European journal of nuclear medicine and molecular imaging, , Volume: 33, Issue:5, 2006
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.European journal of nuclear medicine and molecular imaging, , Volume: 32, Issue:1, 2005
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.European journal of nuclear medicine and molecular imaging, , Volume: 32, Issue:1, 2005
Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.Annals of nuclear medicine, , Volume: 19, Issue:8, 2005
Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.Annals of nuclear medicine, , Volume: 18, Issue:4, 2004
Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 45, Issue:8, 2004
Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.Journal of neurosurgery, , Volume: 99, Issue:3, 2003
Imaging gliomas with positron emission tomography and single-photon emission computed tomography.Seminars in nuclear medicine, , Volume: 33, Issue:2, 2003
Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:5, 1998
Crossed cerebellar diaschisis and brain tumor biochemistry studied with positron emission tomography, [18F]fluorodeoxyglucose and [11C]methionine.Journal of the neurological sciences, , Volume: 156, Issue:1, 1998
F-Dopa as an amino acid tracer to detect brain tumors.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:7, 1996
The demonstration of extension of high-grade glioma beyond magnetic resonance imaging defined edema by the use of (11) C-methionine positron emission tomography.Journal of cancer research and therapeutics, , Volume: 9, Issue:4
Individual radiation response of parotid glands investigated by dynamic 11C-methionine PET.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, , Volume: 78, Issue:3, 2006
Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, , Volume: 52, Issue:3, 1999
Carbon-11-methionine uptake in squamous cell head and neck cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:8, 1998
Target definition by C11-methionine-PET for the radiotherapy of brain metastases.International journal of radiation oncology, biology, physics, , Jul-01, Volume: 74, Issue:3, 2009
The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.Annals of nuclear medicine, , Volume: 22, Issue:6, 2008
18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy.Annals of nuclear medicine, , Volume: 18, Issue:8, 2004
Usefulness of PET with 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 41, Issue:2, 2000
Can 11C-methionine play a role in lung cancer staging?Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 41, Issue:2, 2000
Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:4, 1998
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:9, 1996
Carbon-11-methionine PET imaging of malignant melanoma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 36, Issue:10, 1995
[Comparative analysis of the informative value of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography in the differential diagnosis of solitary lung masses].Vestnik rentgenologii i radiologii, , Issue:3
Can 11C-methionine play a role in lung cancer staging?Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 41, Issue:2, 2000
Usefulness of PET with 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 41, Issue:2, 2000
Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, , Volume: 52, Issue:3, 1999
Carbon-11-methionine PET imaging of malignant melanoma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 36, Issue:10, 1995
Analysis of progression and recurrence of meningioma using (11)C-methionine PET.Annals of nuclear medicine, , Volume: 27, Issue:8, 2013
F-18 FDG and C-11 methionine PET/CT in intracranial dural metastases.Clinical nuclear medicine, , Volume: 37, Issue:2, 2012
C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.Clinical nuclear medicine, , Volume: 21, Issue:7, 1996
Incidental Finding of an Ovarian Carcinoid on 11C-Methionine PET/CT.Clinical nuclear medicine, , Volume: 45, Issue:11, 2020
[PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients].Terapevticheskii arkhiv, , Jul-15, Volume: 91, Issue:7, 2019
11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement.Theranostics, , Volume: 6, Issue:2, 2016
11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma.Oncotarget, , Apr-10, Volume: 6, Issue:10, 2015
[Lacunar stroke as a very late complication of radiotherapy: value of nuclear medicine techniques].Revista de neurologia, , Dec-16, Volume: 71, Issue:12, 2020
Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, , Volume: 44, Issue:2, 2019
Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography.European radiology, , Volume: 28, Issue:8, 2018
Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors.Clinical nuclear medicine, , Volume: 37, Issue:2, 2012
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.European journal of nuclear medicine and molecular imaging, , Volume: 32, Issue:1, 2005
Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.Annals of nuclear medicine, , Volume: 18, Issue:4, 2004
From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology.Annals of nuclear medicine, , Volume: 15, Issue:6, 2001
Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, , Volume: 52, Issue:3, 1999
C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.Clinical nuclear medicine, , Volume: 21, Issue:7, 1996
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:9, 1996
Clinical decision-making based on 11C-methionine PET in recurrent Cushing's disease with equivocal MRI findings.Journal of neurosurgery, , Dec-01, Volume: 139, Issue:6, 2023
Evaluation of the biodistribution of 11C-methionine in children and young adults.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 54, Issue:11, 2013
Dynamic 11C-methionine PET analysis has an additional value for differentiating malignant tumors from granulomas: an experimental study using small animal PET.European journal of nuclear medicine and molecular imaging, , Volume: 38, Issue:10, 2011
From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology.Annals of nuclear medicine, , Volume: 15, Issue:6, 2001
Diagnostic utility of Clinical endocrinology, , Volume: 99, Issue:3, 2023
Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?World journal of surgery, , Volume: 41, Issue:4, 2017
11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.Nuklearmedizin. Nuclear medicine, , Volume: 54, Issue:1, 2015
Hyperparathyroidism caused by retroesophageal adenoma located with C-11 methionine PET/CT in a morbidly obese patient.Surgery, , Volume: 157, Issue:1, 2015
A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia.Nuclear medicine communications, , Volume: 36, Issue:1, 2015
18F-FDG PET rarely provides additional information to 11C-methionine PET imaging in hyperparathyroidism.Clinical nuclear medicine, , Volume: 39, Issue:3, 2014
Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT.Annals of surgery, , Volume: 257, Issue:6, 2013
Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia.Diagnostic and interventional radiology (Ankara, Turkey), , Volume: 17, Issue:4, 2011
C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, , Volume: 42, Issue:3, 2010
Localization of parathyroid adenomas using 11C-methionine positron emission tomography.Nuclear medicine communications, , Volume: 26, Issue:2, 2005
C-11 methionine uptake in granulomatous disease.Clinical nuclear medicine, , Volume: 29, Issue:9, 2004
Use of co-registered 11C-methionine PET and computed tomography for the localisation of parathyroid adenomas.European journal of nuclear medicine and molecular imaging, , Volume: 30, Issue:11, 2003
PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:11, 1996
Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism.Revista espanola de medicina nuclear e imagen molecular, , Volume: 33, Issue:2
Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomas.Molecular imaging and biology, , Volume: 11, Issue:5
11C-methionine-PET for differentiating recurrent brain tumor from radiation necrosis: radiomics approach with random forest classifier.Scientific reports, , 10-30, Volume: 9, Issue:1, 2019
Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions.Annals of nuclear medicine, , Volume: 25, Issue:3, 2011
Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.Annals of nuclear medicine, , Volume: 18, Issue:4, 2004
Delayed cerebral radionecrosis with a high uptake of 11C-methionine on positron emission tomography and 201Tl-chloride on single-photon emission computed tomography.Neuroradiology, , Volume: 40, Issue:7, 1998
Hyperperfusion and hypermetabolism in brain radiation necrosis with epileptic activity.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 37, Issue:7, 1996
Persistent Nontumoral High-Amino-Acid Uptake on Brain [11C]Methionine PET/CT in a Patient After Combined Glioma Treatment.Clinical nuclear medicine, , Jul-01, Volume: 46, Issue:7, 2021
11C-methionine-PET for differentiating recurrent brain tumor from radiation necrosis: radiomics approach with random forest classifier.Scientific reports, , 10-30, Volume: 9, Issue:1, 2019
Diagnostic accuracy of Annals of nuclear medicine, , Volume: 32, Issue:2, 2018
Value of the visual and semiquantitative analysis of carbon-11-methionine PET/CT in brain tumors' recurrence versus post-therapeutic changes.Nuclear medicine communications, , Volume: 38, Issue:12, 2017
Detection of glioma recurrence by ¹¹C-methionine positron emission tomography and dynamic susceptibility contrast-enhanced magnetic resonance imaging: a meta-analysis.Nuclear medicine communications, , Volume: 34, Issue:8, 2013
Evaluation of the biodistribution of 11C-methionine in children and young adults.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 54, Issue:11, 2013
Analysis of progression and recurrence of meningioma using (11)C-methionine PET.Annals of nuclear medicine, , Volume: 27, Issue:8, 2013
Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions.Annals of nuclear medicine, , Volume: 25, Issue:3, 2011
[Usability of 11C-methionine PET in diagnosis of glioma].Gan to kagaku ryoho. Cancer & chemotherapy, , Volume: 37, Issue:6, 2010
Diverse Patterns and Clinical Significance of 11C-Methionine PET in Dysembryoplastic Neuroepithelial Tumors.Clinical nuclear medicine, , Dec-01, Volume: 47, Issue:12, 2022
Carbon-11-methionine PET in focal cortical dysplasia: a comparison with fluorine-18-FDG PET and technetium-99m-ECD SPECT.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, , Volume: 39, Issue:6, 1998
18 F-THK5351 PET Can Evaluate Tumor Extension in Intravascular Large B-Cell Lymphoma : Comparison With 11C-Methionine PET and 18F-FDG PET.Clinical nuclear medicine, , Apr-01, Volume: 48, Issue:4, 2023
Differentiation of newly diagnosed glioblastoma multiforme and intracranial diffuse large B-cell Lymphoma using (11)C-methionine and (18)F-FDG PET.Clinical nuclear medicine, , Volume: 37, Issue:9, 2012
(11)C-methionine PET/CT and MRI of primary central nervous system diffuse large B-cell lymphoma before and after high-dose methotrexate.Clinical nuclear medicine, , Volume: 37, Issue:10, 2012
Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma.Japanese journal of clinical oncology, , May-05, Volume: 50, Issue:5, 2020
Discrimination between primary low-grade and high-grade glioma with The British journal of radiology, , Volume: 91, Issue:1082, 2018
Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings.Annals of nuclear medicine, , Volume: 24, Issue:5, 2010
Pharmacokinetics (3)
Dosage (1)